Earnings Ahead

KLDO - Kaleido Biosciences

0.0001 0.0001 10000

Kaleido Biosciences

Kaleido Biosciences

About

Profile


Headquarters

Bedford, Massachusetts, United States


Intraday

High
-
Low
-

52-week

High
-
Low
-

KLDO



 
...

Available for logged in users only.



The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.
  • Kaleido Biosciences to delist from Nasdaq as business operations end
  • Kaleido Bio discontinues Phase 2 KB109 study, ends collaboration with COPD Foundation
  • Kaleido Biosciences picked industry veteran as chief medical officer
  • Kaleido Biosciences EPS misses by $0.02, misses on revenue
  • Kaleido hits a 52-week low as Morgan Stanley downgrades on lack of catalysts
  • Small Kaleido ulcerative colitis study fails to impress investors as shares decline
  • Kaleido shares topline data from non-IND study for ulcerative colitis candidate
  • Kaleido Biosciences EPS beats by $0.01, beats on revenue
  • Kaleido Biosciences and COPD Foundation ink strategic collaboration to study KB109
  • Seres Therapeutics extends losses as Goldman Sachs downgrades on trial setback
  • Kaleido Biosciences appoints Jerald Korn as Chief Operating Officer
  • Osmotica Pharmaceuticals, Star Equity leads healthcare gainers; Theravance Biopharma, Corbus Pharmaceuticals among major losers
  • Kaleido Biosciences, Pieris Pharmaceuticals leads healthcare gainers; Portage Biotech, Rite Aid among major losers
  • SCOR, GOGL, KLDO and APM among after-hours movers
  • Kaleido Biosciences EPS misses by $0.01
  • Kaleido Bio's KB109 shows positive effect in COVID-19 symptoms
  • Kaleido Biosciences EPS beats by $0.11
  • Kaleido Bio CEO discloses company position
  • Underwriters exercise option for additional shares in Kaleido public offering
  • Kaleido Biosciences announces $50M proposed public offering

Earnings History

Date EPS / Forecast Revenue / Forecast
November 1, 2021 -0.54 / -0.5417 104K / 170K
August 11, 2021 -0.56 / -0.58 211K / 91.67K Beat!
May 20, 2021 - / -0.51 - / -
May 4, 2021 -0.58 / -0.594 297K / - Beat!
March 3, 2021 -0.56 / -0.3983 243K / 9M Beat!
November 2, 2020 -0.65 / -0.62 482K / - Beat!
August 4, 2020 -0.59 / -0.59 - / - Beat!
May 14, 2020 -0.64 / -0.64 - / - Beat!
March 2, 2020 -0.65 / -0.34 - / 10.00M Beat!
October 30, 2019 -0.74 / -0.89 250.0K / - Beat!
August 1, 2019 -0.83 / -0.71 250.0K / - Beat!
Date Price Open High Low Vol Change ER
Mar 23 1.770 1.780
1.842
1.760
72.76K -1.67%
Mar 22 1.800 1.680
1.800
1.680
135.14K 9.09%
Mar 21 1.650 1.730
1.730
1.600
100.20K -1.79%
Mar 18 1.680 1.610
1.750
1.600
147.91K 4.35%
Mar 17 1.610 1.450
1.610
1.441
61.61K 11.81%
 
Mar 16 1.440 1.430
1.460
1.370
67.02K 3.60%
Mar 15 1.390 1.350
1.440
1.330
73.83K 2.96%
Mar 14 1.350 1.380
1.380
1.340
81.90K -0.74%
Mar 11 1.360 1.380
1.450
1.350
34.10K -2.86%
Mar 10 1.400 1.570
1.610
1.370
64.42K -9.09%
Mar 9 1.540 1.380
1.560
1.360
112.00K 14.07%
Mar 8 1.350 1.330
1.470
1.300
79.47K 2.27%
Mar 7 1.320 1.300
1.400
1.300
72.84K 1.54%
Mar 4 1.300 1.410
1.470
1.300
151.31K -7.8%
Mar 3 1.410 1.490
1.550
1.400
44.26K -3.42%
Mar 2 1.460 1.490
1.493
1.450
65.50K 0.69%
Mar 1 1.450 1.500
1.526
1.450
74.15K -2.68%
Feb 28 1.490 1.510
1.564
1.440
76.59K 0.68%
Feb 25 1.480 1.610
1.610
1.460
73.05K -1.99%
Feb 24 1.510 1.450
1.520
1.350
115.18K 2.72%